Shares in BOT are breaking out this morning, up 8% on increasing volume on completion of bowl pattern with a target price around 10c:
Human trials are in progress for both acne and dermatitis using their lead compound (synthetic CBP) and a proprietary drug delivery technology called Permetrex.
Compared to other medical marijuana companies BOT hasn't had the same run but has been building a solid base for a re-rate, which appears to be happening now.
Human safety studies were completed successfully last year and with efficacy results for human trails due Q1 the FA and TA are lining up nicely for BOT to emerge as one of the true medical marijuana stars of 2018.
-
- There are more pages in this discussion • 100 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
15.5¢ |
Change
-0.010(6.06%) |
Mkt cap ! $303.9M | |||
| Open | High | Low | Value | Volume |
| 17.0¢ | 17.0¢ | 15.5¢ | $2.048M | 12.88M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 41 | 2125231 | 15.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.0¢ | 1374370 | 19 |
View Market Depth
| Last trade - 16.14pm 11/07/2025 (20 minute delay) ? |
| BOT (ASX) Chart |